"This information includes how they are manufactured, whether they are sterile, how they work in the body, what side effects they may cause and what substances these products actually contain." The regulator said examples of unapproved peptide products included those containing BPC157, GHKCu, TB500, retatrutide and CJC1295, often supplied in injectable form
The formula is intended for daily use to support gut barrier function, beneficial microbial populations, and healthy immune communication within the gastrointestinal tract
Get Started Today by ensuring your research is built on a foundation of quality you can trust
Clinical experience suggests good tolerability, with: Mild injection site reactions Occasional digestive changes (particularly with oral administration) Rarely reported headache Important Safety Considerations Both peptides should be prescribed and monitored by qualified medical providers Quality of peptide sourcing matters compounding pharmacies should be licensed and regulated Lab monitoring (particularly IGF-1 for sermorelin) is essential for ongoing safety Contraindications (active malignancies, certain medical conditions) must be evaluated Medical Disclaimer Sermorelin was previously FDA-approved for diagnostic use (Geref Diagnostic) and is currently prescribed off-label through compounding pharmacies
For gastrointestinal indications, oral BPC-157 is appropriate because the gut is the target and the peptide does not need to travel further
Purity is a critical parameter, and we utilize High-Performance Liquid Chromatography (HPLC) to analyze each lot
